The European pharma market is a crossroads. Amid the industry-wide "patent cliff," a new wave of capital is flowing into start-ups, driven by venture capital's role in filling funding gaps and pharma's strategic shift toward acquisitions. This session will provide a clear roadmap of the evolving investment landscape. From exploring European initiatives and breakthrough technologies like AI and machine learning, join our experts as they will be highlighting key investment pathways and collaboration models to accelerate innovation and growth.
